Sponsor content

Revolutionizing the way cancer is diagnosed

VolitionRx, a life sciences company, has developed an array of simple blood tests to improve the detection of a wide range of cancers at early stages, with the goal of dramatically improving survival rates in patients. To download the full article, please sign in.

Go to the profile of VolitionRx
Mar 22, 2016
0
0
Upvote 0 Comment
Page of
Go to the profile of VolitionRx

VolitionRx

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The NuQ® tests are based on our Nucleosomics® technology platform, a simple immunoassay based approach to identify and measure epigenetic features of nucleosomes in the bloodstream – an indication that cancer is present. VolitionRx's goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx's research and development activities are currently centred in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the U.S. and ultimately, worldwide.

No comments yet.